This narrative review summarizes literature on C. difficile and C. difficile infections (CDI) that
emerged from Latin America (LA) between 1984 and 2021. The revised information includes …

Clostridioides difficile infection (CDI) may recur in approximately 10–30% of patients, and
the risk of recurrence increases with each successive recurrence, reaching up to 65%. C …

The administration of broad-spectrum antibiotics is often associated with antibiotic-
associated diarrhea (AAD), and impacts gastrointestinal tract homeostasis, as evidenced by …

Background Clostridioides difficile infection (CDI) causes a major burden to individuals and
society, yet the impact may vary depending on age, sex, underlying comorbidities and where …

Clostridioides difficile (C. difficile) is a predominant nosocomial infection, and guidelines for
improving diagnosis and treatment were published in 2017. We conducted a single-center …

Purpose There are currently no standard definitions for assessing the severity of
Clostridioides difficile infection (CDI) in cancer patients. We evaluated the performance of …

La infección por Clostridioides difficile (ICD) es una de las más importantes infecciones
intrahospitalarias. Se realizó un estudio observacional que describe la incidencia, las …

Toxin-producing Clostridioides difficile infection (CDI) is the leading cause of hospital-
acquired diarrhea. However, it is now recognized as a cause of diarrhea in the community …

Clostridioides difficile es una bacteria anaerobia que provoca desde colitis leve hasta colitis
pseudomembranosa y enfermedad refractaria al tratamiento fulminante y fatal (1). La …

La Infección por Clostridioides difficile (ICD), es reconocida como una de las principales
infecciones asociadas a la atención de la salud. Aunque tradicionalmente esta bacteria se …